PARP inhibitor combinations with Olaparib for synergistic efficacy in Olaparib-resistant triple-negative breast cancer cells
Triple-negative breast cancer (TNBC) is associated with aggressive and heterogenous tumour phenotype, early tumour relapse and poor prognosis than other types of invasive breast cancer. TNBC does not respond to endocrine therapy due to the lack of oestrogen receptor (ER), progesterone receptor (P...
| मुख्य लेखक: | |
|---|---|
| स्वरूप: | थीसिस |
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
2023
|
| विषय: | |
| ऑनलाइन पहुंच: | http://psasir.upm.edu.my/id/eprint/118100/1/118100.pdf |